Gudrun Lange

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: LinkedIn

Gudrun Lange, PhD, is a clinical neuropsychologist who works with Dr. Benjamin Natelson at the Pain & Fatigue Study Center, New York, New York. There she heads studies on brain fog in chronic fatigue syndrome and fibromyalgia.[1]

Committees and Boards[edit | edit source]

Notable studies[edit | edit source]

Clinic location[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. "Pain and Fatigue Study Center". www.painandfatigue.com. Retrieved Aug 14, 2018. 
  2. (ASH), Assistant Secretary for Health (Jul 26, 2007). "Roster". HHS.gov. Retrieved Aug 14, 2018. 
  3. "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved Oct 11, 2019. 
  4. Johnson, Susan K.; Lange, Gudrun; Tiersky, Lana; Deluca, John; Natelson, Benjamin H. (Jan 2001). "Health-Related Personality Variables in Chronic Fatigue Syndrome and Multiple Sclerosis". Journal of Chronic Fatigue Syndrome. 8 (3-4): 41–52. doi:10.1300/j092v08n03_05. ISSN 1057-3321. 
  5. Natelson, Benjamin H; Lange, Gudrun (2002), "A status report on chronic fatigue syndrome", Environmental Health Perspectives, 110 (Supp 4): 673–677 
  6. Brimacombe, Michael; Lange, Gudrun; Bisuchio, Kim; Ciccone, Donald S.; Natelson, Benjamin (Jan 2004). "Cognitive Function Index for Patients with Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 12 (4): 3–23. doi:10.1300/j092v12n04_02. ISSN 1057-3321. 
  7. Lange, G; Steffener, J; Cook, DB; Bly, BM; Christodoulou, C; Liu, WC; Deluca, J; Natelson, BH (2005), "Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: a BOLD fMRI study of verbal working memory", NeuroImage, 26 (2): 513-24, doi:10.1016/j.neuroimage.2005.02.011, PMID 15907308 
  8. Togo, Fumiharu; Lange, Gudrun; Natelson, Benjamin H.; Quigley, Karen S. (Sep 24, 2013). "Attention network test: Assessment of cognitive function in chronic fatigue syndrome". Journal of Neuropsychology. 9 (1): 1–9. doi:10.1111/jnp.12030. ISSN 1748-6645. PMID 24112872. 
  9. Lange, Gudrun; Janal, Malvin N.; Maniker, Allen; Fitzgibbons, Jennifer; Fobler, Malusha; Cook, Dane; Natelson, Benjamin H. (September 2011), "Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial", ain Medicine (Malden, Mass.), 12 (9): 1406–1413, doi:10.1111/j.1526-4637.2011.01203.x, ISSN 1526-4637, PMID 21812908 
  10. Natelson, B.H.; Vu, D.; Mao, X.; Weiduschat, N.; Togo, F.; Lange, G.; Blate, M.; Kang, G.; Coplan, J.D.; Shungu, D.C. (2015). "Effect of milnacipran treatment on ventricular lactate in fibromyalgia: A randomized, double-blind, placebo-controlled trial" (PDF). Journal of Pain. 16 (11): 1211–1219. doi:10.1016/j.jpain.2015.08.004. 
  11. Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029 
  12. Natelson, Benjamin; Mao, Xiangling; Stegner, Aaron J; Lange, Gudrun; Vu, Diana; Blate, Michelle; Kang, Guoxin; Soto, Eli; Kapusuz, Tolga; Shungu, Dikoma C (2017), "Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity" (PDF), Journal of the Neurological Sciences, 375: 411-416, doi:10.1016/j.jns.2017.02.046 
  13. Natelson, Benjamin H.; Lin, Jin-Mann S.; Lange, Gudrun; Khan, Sarah; Stegner, Aaron (Nov 2019). "The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome". Annals of Medicine. doi:10.1080/07853890.2019.1683601. 

central nervous system (CNS) - One of the two parts of the human nervous system, the other part being the peripheral nervous system. The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of nerves that travel from the central nervous system into the various organs and tissues of the body.

cognition - Thought processes, including attention, reasoning, and memory.

phase one - A drug trial involving only a small group of humans, often healthy volunteers, to assess drug safety and side effects. Typically 20-80 participants, often using a comparison group.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.